Drug firms seek new strategies
By Wang Hongyi in Shanghai | China Daily | Updated: 2014-11-27 06:47
Multinationals shift sales focus as govt tightens measures to check corruption
Pharmaceutical companies, especially multinationals, are looking for new ways to boost sales as China continues to crackdown on corruption.
Following last year's bribery scandal involving British pharmaceutical giant GlaxoSmithKline, multinational pharmaceutical companies in China are watching their conduct in the market. And they know that what they used to do, with sales representatives playing a pivotal role, will no longer be workable in the new market environment.
Photo